Elon Musk’s Neuralink Raises $650 Million in Funding
Neuralink, Elon Musk’s brain computer interface startup, has closed a $650 million funding round, as announced in a blog post on Monday. The Series E fundraise included major investors like ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others.
Advancements in Brain Chip Technology
Neuralink had previously raised $280 million in a Series D funding round in 2023, with an additional $43 million tranche added later. Since then, the company’s brain chip technology has seen significant progress.
Human Clinical Trials and FDA Breakthrough Designation
Neuralink has conducted more human clinical trials, implanting its brain chips in five individuals with severe paralysis. In May, the company received breakthrough device designation from the U.S. Food and Drug Administration, which aims to accelerate the development, assessment, and review processes for experimental technologies.
Valuation and Future Outlook
The latest deal values Neuralink at around $9 billion pre-money, according to Semafor’s report last week. With this significant funding and advancements in their technology, Neuralink is poised to continue making strides in the field of brain-computer interfaces.
